Aspirin did not provide any clinical benefits in a cohort of patients with colorectal cancer who had no history of cardiovascular disease or stroke.

Taking a low dose of daily aspirin is known to have some health benefits. For example, it can help reduce the risk of heart ...

WEDNESDAY, Jan. 29, 2025 (HealthDay News) -- Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says. Taking 160 milligrams of ...

Aspirin reduced colorectal cancer recurrence risk by 50% in patients with PIK3CA mutations over three years. Mutations in the PI3K pathway predict aspirin response, broadening its use to more patients ...

In one trial, 635 patients with previously resected colorectal cancer received daily aspirin (325 mg) or placebo. During an average follow-up of 31 months (during which most patients underwent 1 ...

Opens in a new tab or window SAN FRANCISCO -- In an era dominated by pricey, high-tech drugs, the humble aspirin had a practice-changing impact on colorectal cancer (CRC) recurrence, according to ...

Please provide your email address to receive an email when new articles are posted on . Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations ...

Health guidelines now advise against the practice for most people, because it increases likelihood of brain and ...

Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says. Taking 160 milligrams of aspirin a day cuts the risk of cancer ...

Cancer risk was cut by half in patients with a mutation that makes them more susceptible Overall, aspirin patients were 55% less likely to have cancer recur than those taking a placebo WEDNESDAY ...